|
US4000137A
(en)
|
1975-06-10 |
1976-12-28 |
American Home Products Corporation |
Antitumor derivatives of periodate-oxidized nucleosides
|
|
US4140761A
(en)
|
1977-04-11 |
1979-02-20 |
The United States Of America As Represented By The Department Of Health, Education & Welfare |
Modification of hepatitis B virus infection in chronic carriers of hepatitis B surface antigen
|
|
JPS5668674A
(en)
|
1979-11-08 |
1981-06-09 |
Shionogi & Co Ltd |
5-fluorouracil derivative
|
|
US5223263A
(en)
|
1988-07-07 |
1993-06-29 |
Vical, Inc. |
Liponucleotide-containing liposomes
|
|
US4724232A
(en)
*
|
1985-03-16 |
1988-02-09 |
Burroughs Wellcome Co. |
Treatment of human viral infections
|
|
US4879277A
(en)
|
1985-08-26 |
1989-11-07 |
The United States Of America As Represented By The Department Of Health And Human Services |
Antiviral compositions and methods
|
|
WO1987001284A1
(en)
|
1985-08-26 |
1987-03-12 |
United States Of America, Represented By The Unite |
Inhibition of in vitro infectivity and cytopathic effect of htlv-iii/lav by 2',3'-dideoxynosine, 2',3'-dideoxyguanosine, or 2',3'-dideoxyadenosine
|
|
EP0217580A3
(en)
|
1985-09-17 |
1990-11-07 |
The Wellcome Foundation Limited |
Therapeutic nucleosides
|
|
US4916122A
(en)
|
1987-01-28 |
1990-04-10 |
University Of Georgia Research Foundation, Inc. |
3'-Azido-2',3'-dideoxyuridine anti-retroviral composition
|
|
US4788181A
(en)
*
|
1986-09-29 |
1988-11-29 |
The United States Of America As Represented By The Department Of Health And Human Services |
5-substituted-2',3'-dideoxycytidine compounds with anti-HTLV-III activity
|
|
US4963533A
(en)
|
1986-10-24 |
1990-10-16 |
Stichting Rega Vzw (Rega) |
Therapeutic application of dideoxycytidinene
|
|
ATE108183T1
(de)
|
1987-03-24 |
1994-07-15 |
Nycomed Imaging As |
2',3'-dideoxyribofuranoxid-derivate.
|
|
US5185437A
(en)
|
1987-04-09 |
1993-02-09 |
Burroughs Wellcome Co. |
Therapeutic nucleosides
|
|
SE8701605D0
(sv)
|
1987-04-16 |
1987-04-16 |
Astra Ab |
Novel medicinal compounds
|
|
AU2526188A
(en)
|
1987-09-22 |
1989-04-18 |
Regents Of The University Of California, The |
Liposomal nucleoside analogues for treating aids
|
|
NZ228645A
(en)
|
1988-04-11 |
1991-09-25 |
Iaf Biochem Int |
1,3-dioxolane derivatives substituted in the 5th position by a purine or pyrimidine radical; treatment of viral infections
|
|
US5041449A
(en)
|
1988-04-11 |
1991-08-20 |
Iaf Biochem International, Inc. |
4-(nucleoside base)-substituted-1,3-dioxolanes useful for treatment of retroviral infections
|
|
US5047407A
(en)
|
1989-02-08 |
1991-09-10 |
Iaf Biochem International, Inc. |
2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
|
|
US5270315A
(en)
|
1988-04-11 |
1993-12-14 |
Biochem Pharma Inc. |
4-(purinyl bases)-substituted-1,3-dioxlanes
|
|
US5466806A
(en)
|
1989-02-08 |
1995-11-14 |
Biochem Pharma Inc. |
Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
|
|
US4900828A
(en)
|
1988-05-12 |
1990-02-13 |
Hoffmann-Laroche Inc. |
Intermediate compounds and an improved procedure for the synthesis of 2',3'-dideoxycytidine
|
|
GB8815265D0
(en)
|
1988-06-27 |
1988-08-03 |
Wellcome Found |
Therapeutic nucleosides
|
|
SE8802687D0
(sv)
|
1988-07-20 |
1988-07-20 |
Astra Ab |
Nucleoside derivatives
|
|
DE68922903T2
(de)
|
1988-12-19 |
1995-11-23 |
Wellcome Found |
Antivirale Pyrimidin- und Purinverbindungen, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate.
|
|
DK0674634T3
(da)
|
1989-02-08 |
2003-08-04 |
Iaf Biochem Int |
Fremgangsmåde til fremstilling af substituerede 1,3-oxathiolaner med antivirale egenskaber
|
|
UA45942A
(uk)
|
1989-02-08 |
2002-05-15 |
Біокем Фарма, Інк. |
1,3-оксатіолан, його похідні, спосіб (варіанти) його одержання та фармацевтична композиція
|
|
NZ233197A
(en)
|
1989-04-13 |
1991-11-26 |
Richard Thomas Walker |
Aromatically substituted nucleotide derivatives, intermediates therefor and pharmaceutical compositions
|
|
US5059690A
(en)
|
1990-03-01 |
1991-10-22 |
E. R. Squibb & Sons, Inc. |
Purinyl tetrahydrofurans
|
|
US5194654A
(en)
|
1989-11-22 |
1993-03-16 |
Vical, Inc. |
Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
|
|
US5411947A
(en)
|
1989-06-28 |
1995-05-02 |
Vestar, Inc. |
Method of converting a drug to an orally available form by covalently bonding a lipid to the drug
|
|
US5463092A
(en)
|
1989-11-22 |
1995-10-31 |
Vestar, Inc. |
Lipid derivatives of phosphonacids for liposomal incorporation and method of use
|
|
IE904378A1
(en)
|
1989-12-20 |
1991-07-03 |
Abbott Lab |
Analogs of oxetanyl purines and pyrimidines
|
|
US5204466A
(en)
|
1990-02-01 |
1993-04-20 |
Emory University |
Method and compositions for the synthesis of bch-189 and related compounds
|
|
US5276151A
(en)
|
1990-02-01 |
1994-01-04 |
Emory University |
Method of synthesis of 1,3-dioxolane nucleosides
|
|
GB9009861D0
(en)
|
1990-05-02 |
1990-06-27 |
Glaxo Group Ltd |
Chemical compounds
|
|
AU7872491A
(en)
|
1990-05-07 |
1991-11-27 |
Vical, Inc. |
Lipid prodrugs of salicylate and nonsteroidal anti-inflammatory drugs
|
|
EP0531452A4
(en)
|
1990-05-29 |
1993-06-09 |
Vical, Inc. |
Synthesis of glycerol di- and triphosphate derivatives
|
|
ATE131825T1
(de)
|
1990-06-13 |
1996-01-15 |
Arnold Glazier |
Phosphorylierte prodrugs
|
|
FR2663636B1
(fr)
|
1990-06-26 |
1992-10-09 |
Centre Nat Rech Scient |
Procede de fonctionnalisation d'un oligonucleotide.
|
|
SE9003151D0
(sv)
|
1990-10-02 |
1990-10-02 |
Medivir Ab |
Nucleoside derivatives
|
|
US5543389A
(en)
|
1990-11-01 |
1996-08-06 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University, A Non Profit Organization |
Covalent polar lipid-peptide conjugates for use in salves
|
|
US5149794A
(en)
|
1990-11-01 |
1992-09-22 |
State Of Oregon |
Covalent lipid-drug conjugates for drug targeting
|
|
US5543390A
(en)
|
1990-11-01 |
1996-08-06 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University |
Covalent microparticle-drug conjugates for biological targeting
|
|
US5256641A
(en)
|
1990-11-01 |
1993-10-26 |
State Of Oregon |
Covalent polar lipid-peptide conjugates for immunological targeting
|
|
EP0560794B1
(en)
|
1990-11-13 |
1996-09-18 |
Biochem Pharma Inc |
Substituted 1,3-oxathiolanes with antiviral properties
|
|
US5587480A
(en)
|
1990-11-13 |
1996-12-24 |
Biochem Pharma, Inc. |
Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties
|
|
US5925643A
(en)
|
1990-12-05 |
1999-07-20 |
Emory University |
Enantiomerically pure β-D-dioxolane-nucleosides
|
|
US5248776A
(en)
|
1990-12-05 |
1993-09-28 |
University Of Georgia Research Foundation, Inc. |
Process for enantiomerically pure β-L-1,3-oxathiolane nucleosides
|
|
WO1992010496A1
(en)
|
1990-12-05 |
1992-06-25 |
University Of Georgia Research Foundation, Inc. |
ENANTIOMERICALLY PURE β-L-(-)-1,3-OXATHIOLANE NUCLEOSIDES
|
|
US5179104A
(en)
|
1990-12-05 |
1993-01-12 |
University Of Georgia Research Foundation, Inc. |
Process for the preparation of enantiomerically pure β-D-(-)-dioxolane-nucleosides
|
|
US5444063A
(en)
|
1990-12-05 |
1995-08-22 |
Emory University |
Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity
|
|
IL100502A
(en)
|
1991-01-03 |
1995-12-08 |
Iaf Biochem Int |
PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (-
|
|
NZ241625A
(en)
*
|
1991-02-22 |
1996-03-26 |
Univ Emory |
1,3-oxathiolane derivatives, anti-viral compositions containing such and method of resolving racemic mixture of enantiomers
|
|
NZ264621A
(en)
|
1991-03-06 |
1997-09-22 |
Wellcome Found |
Use of 1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-5-fluoro-cytosine or a physiologically functional derivative thereof in the preparation of medicaments for treatment of hepatitis b
|
|
GB9104740D0
(en)
|
1991-03-06 |
1991-04-17 |
Wellcome Found |
Antiviral nucleoside combination
|
|
WO1992018517A1
(en)
|
1991-04-17 |
1992-10-29 |
Yale University |
Method of treating or preventing hepatitis b virus
|
|
GB9110874D0
(en)
|
1991-05-20 |
1991-07-10 |
Iaf Biochem Int |
Medicaments
|
|
ZA923640B
(en)
*
|
1991-05-21 |
1993-02-24 |
Iaf Biochem Int |
Processes for the diastereoselective synthesis of nucleosides
|
|
GB9111902D0
(en)
|
1991-06-03 |
1991-07-24 |
Glaxo Group Ltd |
Chemical compounds
|
|
AU668873B2
(en)
*
|
1991-07-12 |
1996-05-23 |
Chimerix, Inc. |
Antiviral liponucleosides: treatment of hepatitis B
|
|
US5554728A
(en)
|
1991-07-23 |
1996-09-10 |
Nexstar Pharmaceuticals, Inc. |
Lipid conjugates of therapeutic peptides and protease inhibitors
|
|
GB9116601D0
(en)
|
1991-08-01 |
1991-09-18 |
Iaf Biochem Int |
1,3-oxathiolane nucleoside analogues
|
|
FR2684997A1
(fr)
|
1991-12-12 |
1993-06-18 |
Centre Nat Rech Scient |
Derives de la 9-(beta-d-xylofurannosyl) adenine et de la 1-(beta-d-xylofurannosyl) cytosine, leur preparation et leur application en therapeutique.
|
|
FR2685331A1
(fr)
|
1991-12-12 |
1993-06-25 |
Centre Nat Rech Scient |
Phosphotriesters de la ddu, leur preparation et leur application en therapeutique.
|
|
FR2684996A1
(fr)
|
1991-12-12 |
1993-06-18 |
Centre Nat Rech Scient |
Derives de 2',3'-didesoxy-3'-aminothymidine, leur preparation et leur application en therapeutique.
|
|
US5849905A
(en)
|
1994-11-23 |
1998-12-15 |
Centre National De La Recherche Scientifique |
Biologically active phosphotriester-type nucleosides and methods for preparing same
|
|
US5770725A
(en)
|
1992-05-25 |
1998-06-23 |
Gosselin; Gilles |
Phosphotriester type biologically active compounds
|
|
FR2692265B1
(fr)
|
1992-05-25 |
1996-11-08 |
Centre Nat Rech Scient |
Composes biologiquement actifs de type phosphotriesters.
|
|
AU4812393A
(en)
|
1992-09-03 |
1994-03-29 |
Biochem Pharma Inc. |
Use of rapamycin in the treatment of aids
|
|
GB9226927D0
(en)
*
|
1992-12-24 |
1993-02-17 |
Iaf Biochem Int |
Dideoxy nucleoside analogues
|
|
FR2705099B1
(fr)
|
1993-05-12 |
1995-08-04 |
Centre Nat Rech Scient |
Oligonucléotides phosphorothioates triesters et procédé de préparation.
|
|
EP0746319A4
(en)
|
1993-05-12 |
1997-11-05 |
Karl Y Hostetler |
ACYCLOVIR DERIVATIVES FOR TOPICAL USE
|
|
TW374087B
(en)
*
|
1993-05-25 |
1999-11-11 |
Univ Yale |
L-2',3'-dideoxy nucleotide analogs as anti-hepatitis B(HBV) and anti-HIV agents
|
|
US5627160A
(en)
*
|
1993-05-25 |
1997-05-06 |
Yale University |
L-2',3'-dideoxy nucleoside analogs as anti-hepatitis B (HBV) and anti-HIV agents
|
|
EP0631783A1
(en)
*
|
1993-06-03 |
1995-01-04 |
Mitsubishi Chemical Corporation |
Antiviral combinations of 2',3'-di-deoxyribonucleosides with 6-benzyl-1-ethoxymethyl-5-substituted uracil derivatives
|
|
FR2709754B1
(fr)
|
1993-09-10 |
1995-12-01 |
Centre Nat Rech Scient |
Composés 2' ou 3'-déoxy- et 2', 3'-didéoxy-beta-L-pentofuranonucléosides, procédé de préparation et application thérapeutique, notamment anti-virale.
|
|
CA2637774C
(en)
|
1993-09-10 |
2011-07-19 |
Emory University |
Nucleosides with anti-hepatitis b virus activity
|
|
FR2711655A1
(fr)
|
1993-10-21 |
1995-05-05 |
Centre Nat Rech Scient |
Composés 3'-phosphononucléosides et procédé de préparation.
|
|
US5587362A
(en)
|
1994-01-28 |
1996-12-24 |
Univ. Of Ga Research Foundation |
L-nucleosides
|
|
US5696277A
(en)
|
1994-11-15 |
1997-12-09 |
Karl Y. Hostetler |
Antiviral prodrugs
|
|
EP0831852B1
(en)
*
|
1995-06-07 |
2006-11-29 |
Emory University |
Nucleosides with anti-hepatitis b virus activity
|
|
ES2255295T3
(es)
*
|
1998-08-10 |
2006-06-16 |
Idenix (Cayman) Limited |
2'-deoxi-beta-l-nucleosidos para el tratamiento de la hepatitis b.
|
|
US6444652B1
(en)
*
|
1998-08-10 |
2002-09-03 |
Novirio Pharmaceuticals Limited |
β-L-2'-deoxy-nucleosides for the treatment of hepatitis B
|